Ionera Bio
Latest round
- Seed
Last raised
- Feb 2026
Total raised
- $0.8M
Investors
- 1
About Ionera Bio
Based in Isreal, Ionara Bio focused on developing novel, proprietary small-molecule therapeutics targeting the TRPV2 (Transient Receptor Potential Vanilloid 2) ion channel. The company develops small-molecule inhibitors of the TRPV2 channel to reduce inflammation driven by macrophages after acute myocardial infarction. Its lead TRPV2 inhibitor aims to preserve cardiac structure and function and limit post-infarction fibrosis.
Who invested in Ionera Bio
1 investor across 2 rounds
See all investors in Ionera Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Ionera Bio
Who invested in Ionera Bio?
Ionera Bio has 1 investor on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ionera Bio raised?
Ionera Bio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Ionera Bio last raise money?
Ionera Bio's most recent round on record is a Seed, in Feb 2026.
What does Ionera Bio do?
Based in Isreal, Ionara Bio focused on developing novel, proprietary small-molecule therapeutics targeting the TRPV2 (Transient Receptor Potential Vanilloid 2) ion channel.
Where is Ionera Bio headquartered?
Ionera Bio is headquartered in Or Yehuda, Israel.
Which VCs invest in companies like Ionera Bio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Ionera Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Ionera Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.